• UCLA Health
  • myUCLAhealth
  • School of Medicine
UCLA AIDS Institute

UCLA AIDS Institute

UCLA AIDS Institute
  • About Us
    • AIDS Institute Firsts
    • Student Activities
    • In The News
    • Insider Magazine
    • Donations and Support
    • Resources for Healthcare Professionals
    • Contact Us
  • Research Programs
    • Biobehavioral Epidemiology and Substance Abuse
    • Basic & Translational Research
    • Clinical Therapeutics & Biomedical Prevention
    • Prevention & Implementation Research
    • International Health Services and Policy
  • Conferences and Seminars
  • Grants
    • Seed Grants
    • White Papers
    • Travel Grants
    • Request for Applications [RFA]
    • Grant Recipients
    • Grant Review Policies
    • NIH Funding Opportunities
    • Logos
  • Our Expert Team
    • Faculty
  • UCLA CARE Center
  • Center for AIDS Research
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA AIDS Institute

About Us

About Us

About Us

  • AIDS Institute Firsts
  • Student Activities
  • In The News
  • Insider Magazine
  • Donations and Support
  • Resources for Healthcare Professionals
    • Multicenter AIDS Cohort Study (MACS)
    • Pacific AIDS Education Training Center (PAETC)
    • Center for HIV Identification, Prevention and Treatment Services (CHIPTS)
  • Contact Us
  • AIDS Institute Firsts
  • Student Activities
  • In The News
  • Insider Magazine
  • Donations and Support
  • Resources for Healthcare Professionals
  • Contact Us
  1. Home
  2. About Us
  3. In The News

In The News

Share this

News

Cancer-fighting gene immunotherapy shows promise as treatment for HIV

A type of immunotherapy that has shown promising results against cancer could also be used against HIV, the virus that causes AIDS. In a study published July 11 in the peer-reviewed Journal of Virology, researchers from the UCLA AIDS Institute and Center for AIDS Research found that recently discovered potent antibodies can be used to generate a specific type of cell called chimeric antigen receptors, or CARs, that can be used to kill cells infected with HIV-1. Read full article »


Combining social media and behavioral psychology could lead to more HIV testing

Social media such as Twitter and Facebook can be valuable in the fight against HIV in the United States, where research has demonstrated they can prompt high-risk populations to request at-home testing kits for the virus that causes AIDS, suggesting a way to potentially boost testing rates.

But does it lead to actual testing, and can it work outside the United States? A new study from the UCLA Center for Digital Behavior published online Dec. 15 by the peer-reviewed journal Lancet HIV suggests that it can. The study, conducted in Peru among men who have sex with men, found that participants in the intervention arm of a randomized controlled clinical trial were more than twice as likely to be tested for HIV than those who joined a social media group and were provided with traditional HIV prevention services.

Read more »

Other News

  • Stem cell gene therapy developed at UCLA holds promise for eliminating HIV infection
  • Vault nanoparticles engineered at UCLA show promise for cancer treatment and possible HIV cure
  • Cocaine use can make otherwise resistant immune cells susceptible to HIV
  • Newly identified natural protein blocks HIV, other deadly viruses
  • Researchers identify possible key to slow progression toward AIDS
  • UCLA-led project aimed at African American couples affected by HIV gets $2.5M boost
  • Drug combo much better than AZT alone at preventing mother-to-infant HIV transmission
  • UCLA-engineered stem cells seek out and kill HIV in living organisms
  • UCLA researchers suggest unconventional approach to control HIV epidemics
  • Early trial suggests rectal microbicide is safe, could significantly reduce HIV transmission
  • Clinical trial uncovers potential 'functional cure' for HIV/AIDS
  • Tenofovir gel protects rectal tissue against HIV, UCLA-led study finds
  • UCLA partnership receives $12 million grant to improve HIV care in Malawi 
  • UCLA researchers demonstrate that stem cells can be engineered to kill HIV
  • State awards $49.2 million to UCLA stem cell scientists to develop new therapies for disease 
  • Circumcision rates lower in states where Medicaid does not cover procedure
  • UCLA researchers demonstrate that stem cells can be engineered to kill HIV
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth